FDA Drug Application (021618) for TINDAMAX by MISSION PHARMA

Back to FDA Applications sponsored by MISSION PHARMA

Application Number021618
Product Number001
FormTABLET;ORAL
Dosage250MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTINDAMAX
Active IngredientTINIDAZOLE

Active IngredientCount
List of drugs with Active Ingredient TINIDAZOLE2


Back to FDA Applications sponsored by MISSION PHARMA